Dr. Antonio Marcilla
Área de Parasitología, Departamento Farmacia y Tecnología Farmacéutica y Parasitología, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de València, and Joing Research Unit on Endocrinology, Nutrition and Clinical Dietetics, Hospital Universitario y Politécnico “La Fe”-Universitat de Valencia
Dr. Antonio Marcilla is Full Professor of Parasitology and leads a research group that studies the role of extracellular vesicles in interkingdom interactions.
He obtained his doctorate in Pharmacy (Department of Microbiology-Universitat de València, Spain) in 1991, working on the characterization of mannoproteins from the cell wall of the pathogenic fungus Candida albicans as a target for specific diagnosis, producing several monoclonal antibodies, some of them commercialized.
As a postdoctoral fellow at the National Institutes of Health (Bethesda, MD, USA) (1993-1995), he was involved in the characterization of protein-protein interactions in signal transduction in cancer cells, primarily basophils, monocytes. and macrophages. Subsequently, he returned to Valencia where he carried out two postdoctoral stays at the Institute of Cytological Research of Valencia (1995-1996) (currently the “Príncipe Felipe” Research Center), and the University of Valencia (1996-1998).
He began his teaching career as Assistant Professor of Parasitology, Faculty of Pharmacy-UV (1998-2002), Associate Professor (2002-2016). He obtained the position of Full Professor in 2016.
Since her appointment at the Department of Parasitology in 1998, he has worked in Molecular Parasitology, initially with Chagas’ disease vectors (producing molecular tools to distinguish triatomine vectors), and later with parasitic trematodes, as well as with the nematode Strongyloides stercoralis. He has been involved in the analysis and molecular characterization of the host-helminth parasite interface, using “–omic” approaches (genomic, transcriptomic and proteomic), in order to identify new and specific targets for its control (diagnostic biomarkers, prognoses, treatment and/or vaccination).
In 2011 he began his research in extracellular vesicles as a source of these targets. His group described for the first time the presence of extracellular vesicles in parasitic helminths, as well as the presence of microRNAs in these vesicles.
Supervisor of 11 Doctoral Theses and more than 20 Master's Theses, he has published more than 120 articles in high-impact scientific journals, with more than 22,265 citations (h-index: 45).
He has been a founding member of the Spanish Group on Extracellular Vesicles (GEIVEX) and also belongs to the International Society of Extracellular Vesicles (ISEV). Member of the editorial board of several prestigious journals in the field of parasitology and extracellular vesicles such as the Journal of Extracellular Vesicles (JEV). He is Member of the Royal National Academy of Pharmacy (Spain).
He obtained his doctorate in Pharmacy (Department of Microbiology-Universitat de València, Spain) in 1991, working on the characterization of mannoproteins from the cell wall of the pathogenic fungus Candida albicans as a target for specific diagnosis, producing several monoclonal antibodies, some of them commercialized.
As a postdoctoral fellow at the National Institutes of Health (Bethesda, MD, USA) (1993-1995), he was involved in the characterization of protein-protein interactions in signal transduction in cancer cells, primarily basophils, monocytes. and macrophages. Subsequently, he returned to Valencia where he carried out two postdoctoral stays at the Institute of Cytological Research of Valencia (1995-1996) (currently the “Príncipe Felipe” Research Center), and the University of Valencia (1996-1998).
He began his teaching career as Assistant Professor of Parasitology, Faculty of Pharmacy-UV (1998-2002), Associate Professor (2002-2016). He obtained the position of Full Professor in 2016.
Since her appointment at the Department of Parasitology in 1998, he has worked in Molecular Parasitology, initially with Chagas’ disease vectors (producing molecular tools to distinguish triatomine vectors), and later with parasitic trematodes, as well as with the nematode Strongyloides stercoralis. He has been involved in the analysis and molecular characterization of the host-helminth parasite interface, using “–omic” approaches (genomic, transcriptomic and proteomic), in order to identify new and specific targets for its control (diagnostic biomarkers, prognoses, treatment and/or vaccination).
In 2011 he began his research in extracellular vesicles as a source of these targets. His group described for the first time the presence of extracellular vesicles in parasitic helminths, as well as the presence of microRNAs in these vesicles.
Supervisor of 11 Doctoral Theses and more than 20 Master's Theses, he has published more than 120 articles in high-impact scientific journals, with more than 22,265 citations (h-index: 45).
He has been a founding member of the Spanish Group on Extracellular Vesicles (GEIVEX) and also belongs to the International Society of Extracellular Vesicles (ISEV). Member of the editorial board of several prestigious journals in the field of parasitology and extracellular vesicles such as the Journal of Extracellular Vesicles (JEV). He is Member of the Royal National Academy of Pharmacy (Spain).
